New Treatment Approaches for Leukemias Emerging From Early Clinical Trials
New Test Predicts Breast Cancer Recurrence And Who Benefits Most From Chemotherapy
Genasense Added To Chemo Improves Responses in CLL
Blacks, Whites Have Same Contralateral Breast Cancer Risk While On Tamoxifen
Of Smokers Screened With CT In Study, 7% Have Lung Cancer
Insulin For Diabetes Increases Risk Of Colorectal Cancer
NCI-Approved Clinical Trials
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
